1 Min Read
Sept 28 (Reuters) - CSL Behring:
* CSL Behring - japan’s ministry of health, labour and welfare approves Afstyla - CSL behring’s novel recombinant Haemophilia A treatment Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.